Bromfenac is an NSAID formulated as an ophthalmic solution to reduce pain and inflammation following cataract surgery. Simson Pharma's Bromfenac reference standard and impurities support the precise impurity control required of this ocular-contact anti-inflammatory.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Bromfenac Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.